ATOR-4066

N/A

Report date: 2024/11/05 09:55:40

Base Information

Drug NameATOR-4066
Drug Alias NameNeo-X-PrimeATOR-4066
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionImmunomodulatorsTumor necrosis factor receptor superfamily member 5 inhibitorsCarcinoembryonic antigen inhibitors
TargetsTumor necrosis factor receptor superfamily member 5Carcinoembryonic antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlligator Bioscience Ab
China Registration ClassN/A

Develop Information

Active CompaniesAlligator Bioscience Ab
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A